Johnson & Johnson’s growth rate

Johnson & Johnson (JNJ) reported a rise of ~0.8% in revenues in constant currencies for 3Q15 over 3Q14. The company’s 3Q15 revenues were $17.1 billion, lower than analysts’ estimates of $7.4 billion.

Johnson & Johnson’s 3Q15 Changes in Growth Rate

Impact of foreign exchange rates

The above graph shows that foreign exchange rates had a constant negative impact on the growth rate of Johnson & Johnson in each quarter. This is mainly because ~50% of total revenues of Johnson & Johnson are reported from sales outside the United States. The company operates ~134 manufacturing facilities and eight innovation and research centers worldwide.

Year-over-Year performance

Johnson & Johnson’s revenues have risen over past few year following the restructuring of its business segments and strong performance of few of its key products including Xarelto, Zytiga, Remicade, Stelara, and Olysio. The 2014 revenues rose by ~4.2% to $74.3 billion, compared to $71.3 billion for 2013.

We’ll discuss 3Q15’s segment-wise revenues and performance in coming articles.

Johnson and Johnson’s revenues fell by ~7.4% in 3Q15 as compared to 3Q14, while the results for other companies are still awaited as on date. VanEck Vectors Pharmaceutical ETF (PPH) invests 7.4% of its portfolio in Johnson & Johnson, 7.9% in Novartis AG (NVS), 5.6% in Pfizer (PFE), and 5.0% in Merck and Co. (MRK). Investors can refer to earnings of other companies on our pharmaceutical earnings overview page.

Latest articles

25 Jun

Gold Breaches $1,400: What’s the Next Stop?

WRITTEN BY Anuradha Garg

Gold is now trading close to a six-year high following the Fed’s dovish pivot at its June policy meeting. After being range-bound for the last five years, gold has finally broken out and its outlook is bullish.

Shares of the J.M. Smucker Company (SJM) are up 29.8% year-to-date as of June 24 and have outperformed the broader markets. The company's acquisition of Ainsworth Pet Nutrition and its focus on high-growth categories via divestitures have supported its stock so far this year.

On June 25, General Motors (GM), America’s largest auto company, announced its plan to invest $20 million into its Arlington Assembly plant in Texas, according to Reuters. With the new investment, the company aims to upgrade its equipment before launching its full-size SUVs.

Shares of high-growth technology company ServiceNow (NOW) have gained close to 16.0% since April 2019. It's gained over 60.0% since the start of 2019. It also had an encouraging run in 2018, when it gained 32.0% in market value.

25 Jun

Ford to Announce Q2 US Sales on July 3: What to Expect

WRITTEN BY Jitendra Parashar

Earlier today, Ford (F) said that it would announce its second-quarter US sales data on July 3. In the first quarter, the company reported a 1.6% YoY decline in its US sales to 590,249 vehicle units. During the first quarter, Ford’s truck sales rose by 4.1%, and its SUV sales went up by 5.0% on a YoY basis.

On June 25, Credit Suisse initiated coverage on Chipotle Mexican Grill with an “outperform” rating and a target price of $870—a return potential of 20.1% from its stock price of $724.13 on June 24.

172.31.71.127